Immunization Agenda 2030

In news : While chairing the 148th session of WHO Executive Board yesterday, Dr. Harsh Vardhan said that the Executive Board welcomed the Immunization Agenda 2030 and unanimously recognized the central role played by immunization programmes in safeguarding public health globally

About  the Immunization Agenda 2030

• The Immunization Agenda 2030 (IA2030) sets an ambitious, overarching global vision and strategy for vaccines and immunization for the decade 2021–2030. 
• It draws on lessons learnt, acknowledges continuing and new challenges posed by infectious diseases and capitalizes on new opportunities to meet those challenges. 
• IA2030 positions immunization as a key contributor to people’s fundamental right to the enjoyment of the highest attainable physical and mental health and also as an investment in the future, creating a healthier, safer, more prosperous world for all. 
• IA2030 aims to ensure that we maintain the hard-won gains and also that we achieve more – leaving no one behind, in any situation or at any stage of life. 

• IA2030 is intended to inspire and align the activities of community, national, regional and global stakeholders – national governments, regional bodies, global agencies, development partners, health care professionals, academic and research institutions, vaccine developers and manufacturers, the private sector and civil society. 
• Its impact will be maximized by more effective and efficient use of resources, innovation to improve performance and measures to attain financial and programmatic sustainability. 
• Success will depend on building and strengthening partnerships within and outside the health sector as part of a coordinated effort to improve access to high quality, affordable primary health care, achieve universal health coverage and accelerate progress towards the 2030 Sustainable Development Goals (SDGs).
• IA2030 provides a long-term strategic framework to guide a dynamic operational phase, responding to changes in country needs and the global context over the next decade.  
• The IA2030 global vision and strategy will be complemented by annexes providing detailed technical information on the strategic framework, together with new and existing strategies and immunization plans, including those for disease specific programmes to control, eliminate or eradicate disease. 
• IA2030 will become operational through regional and national strategies, a mechanism to ensure ownership and accountability and a monitoring and evaluation framework to guide country implementation. 

Strategic priorities

• IA2030 has been developed through a “bottom-up” co-creation process, with close engagement of countries to ensure that the vision, strategic priorities and goals are aligned with country needs. 
• As an adaptive and flexible strategy, the IA2030 framework is designed to be tailored by countries to their local context, and to be revised throughout the decade as new needs and challenges emerge.
• IA2030 strategic priorities will be further refined in the monitoring and evaluation framework and will include indicators, targets and methods for tracking progress.
• IA2030 goals are designed to inspire action for implementation. For countries, this could mean setting country-specific targets and milestones for the decade toward those goals. 
• For regions, this could mean contextualising global goals and setting specific targets and milestones in Regional Vaccination Action Plans. 
• For partner organisations, this could mean aligning organisational strategies and indicators to support the attainment of IA2030 goals.

Core principles

Core principles 

The IA 2030 strategy—to extend the benefits of vaccines to everyone, everywhere—is underpinned by four core principles: it puts people in the center, is led by countries, implemented through broad partnerships, and driven by data. The IA2030 strategy systematically applies the core principles across each of the strategic priorities.